Researchers find new tech to change IV therapies into oral pills
HQ Team October 10, 2024: A study published in Nature Communications discusses a novel water-soluble prodrug technology called Sol-moiety, which enhances the oral bioavailability of
HQ Team October 10, 2024: A study published in Nature Communications discusses a novel water-soluble prodrug technology called Sol-moiety, which enhances the oral bioavailability of
US-based Baxter International Inc., is implementing an allocation policy to limit stockpiling of its drugs after Hurricane Helene ripped through its facility in
As Hurricane Milton looms large over the Florida coast, weather climate researchers said rainfall caused by Hurricane Helene, which struck two weeks before,
Dengue cases in the Americas Region exceeded the number of cases historically reported in a year, as compared to all previously recorded years,
GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season
Sage Therapeutics Inc.’s experimental drug failed to meet its main goal of treating mild dementia due to Alzheimer's disease and the US, Cambridge-headquartered
Glaciers suffered the largest mass loss in 50 years as last year marked the driest for global rivers in 33 years, according to
HQ Team October 8, 2024:Humanity is hitting the upper limit of life expectancy, according to a new study. Medical advances have led to
Johnson and Johnson discontinued a study of an investigational drug to treat bladder cancer after it failed to yield desired results
HQ Team October 7, 2024: Rheumatoid arthritis (RA), an autoimmune disease that causes joint and bone inflammation, is affected by gut bacteria. Researchers